Send Inquiry

Request To Call Back

CIZUMAB BEVACIZUMAB INJECTION

Get a Price/Quote

CIZUMAB BEVACIZUMAB INJECTION Specification

Origin of Medicine
Biological/Pharmaceutical

Indication
Metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, cervical cancer, ovarian cancer

Pacakaging (Quantity Per Box)
1 vial per box

Dosage Form
Injection

Salt Composition
Bevacizumab 400 mg

Drug Type
Prescription only

Ingredients
Bevacizumab

Physical Form
Liquid

Function
Anti-VEGF monoclonal antibody

Recommended For
Anti-cancer therapy

Dosage
As directed by physician

Dosage Guidelines
Intravenous infusion only

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store in a refrigerator at 2C to 8C

Brand Name
Cizumab

Appearance
Clear to slightly opalescent, colorless to pale brownish-yellow liquid

Expiry
24 months from the date of manufacture

Container Type
Glass vial

Regulatory Approval
DCGI approved

Warning
To be administered under medical supervision only

Marketed By
Hetero Healthcare Ltd

Strength
400 mg/16 ml

Prescription Category
Rx only

Therapeutic Class
Oncology

Route of Administration
Intravenous

CIZUMAB BEVACIZUMAB INJECTION Trade Information

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

About CIZUMAB BEVACIZUMAB INJECTION

Cizumab Tablets

Specifications :-

Strength:available in 100 Mg and 400 Mg
Form:Injection
Packaging Size:pack of 1 vial
Manufacturer:Hetero
Composition:Bevacizumab
Brand:CIZUMAB

Note :-CIZUMAB Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Precise Anti-Cancer Treatment

Cizumab contains bevacizumab, a targeted anti-VEGF therapy designed for adults diagnosed with certain solid tumors. Its mechanism of action inhibits the growth of blood vessels that feed tumors, enhancing the efficacy of traditional cancer treatments when used in combination therapy.

High Safety and Regulatory Standards

Cizumab is DCGI-approved and follows stringent regulations for use in oncology. Available in a glass vial, the injection must be administered only by qualified healthcare professionals, ensuring safety and minimizing the risk of complications.

Optimized Packaging & Storage

Packaged as a single vial per box, Cizumab should be stored in a refrigerator (2C to 8C) to preserve its biological integrity. Its pale colorless appearance reflects its pure composition, making it trustworthy for hospitals and cancer care centers.

FAQs of CIZUMAB BEVACIZUMAB INJECTION:

Q: How is Cizumab (Bevacizumab Injection) administered to patients?

A: Cizumab is given as an intravenous infusion by a trained healthcare professional in a hospital or clinical setting. Self-administration is not recommended due to the need for medical supervision and precise dosage control.

Q: What types of cancer are treated with Cizumab?

A: Cizumab is indicated for metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, cervical cancer, and ovarian cancer. Your physician will determine suitability based on your specific diagnosis.

Q: When should Cizumab be administered during a cancer treatment regimen?

A: Cizumab is typically used alongside other chemotherapy agents as directed by your oncologist. It is usually scheduled according to established protocols depending on cancer type, stage, and patient response.

Q: Where should Cizumab be stored before administration?

A: Cizumab must be stored in a refrigerator at 2C to 8C. It should remain in its original glass vial until prepared for infusion by medical staff.

Q: What is the process for receiving a Cizumab infusion?

A: After your prescription is confirmed, a nurse or doctor will prepare and administer the required dose intravenously in a registered medical facility, monitoring for any adverse reactions during and after the infusion.

Q: What are the benefits of using Cizumab in cancer therapy?

A: Cizumab helps block blood vessel formation in tumors, restricting their growth and spread. This enhances the effectiveness of standard cancer therapies and may help improve overall treatment outcomes for eligible patients.

Q: Is Cizumab suitable for pediatric patients?

A: No, Cizumab is currently recommended only for adult patients as per its regulatory and clinical guidelines. Pediatric use is not approved or supported by existing evidence.

Tell us about your requirement